Stocks
Sarepta Therapeutics (SRPT) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -20.0 | -18.4 | -19.0 | 36.4 | -3.63 | 20.4 | ||
| Changes by years, y/y, % | -27% | -8% | +3% | -292% | -110% | -33.2% | |||
Sarepta Therapeutics. EV/EBITDA
Sarepta Therapeutics. EV/EBITDA, changes, %
Sarepta Therapeutics (SRPT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -66.0 | 61.8 | -12.9 | -3.80 | 21.9 | 20.4 | |
| Changes by years, y/y, % | -152% | -49% | -120% | -110% | -133% | |||
| Changes by quarters, q/q, % | -279% | -194% | -121% | -71% | -677% | |||
